News

Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies

Featured Posts

Penn Engineers Unlock the Potential for a New Generation of Wireless Communications

Researchers , have developed an adjustable high frequency filter that prevents signal interference in wireless communications and data transfers.

New Mini-documentary Showcases the Path to CAR-T Cell Therapy  

This short documentary tells the powerful story of Bruce Levine, PhD, the Barbara and Edward Netter Professor in Cancer Gene Therapy at Penn Medicine, and the successful use of CAR-T cell therapy.

Penn Engineering Faculty Attend AI & Energy Summit in Pittsburgh   

Penn Engineering faculty showcased Penn research, technologies, and start-up companies in the fields of energy, AI and computing.

Penn Health-Tech’s Katie Reuther Publishes Life Sciences Pitch Deck Guide in Nature Biotechnology

Katie Reuther, PhD, MBA, the Executive Director of Penn Health-Tech and a Practice Associate Professor in Bioengineering at Penn Engineering, published a career feature in Nature Biotechnology.

David Meaney Named Vice Provost for Research and Mark Dingfield Named Executive Vice President at Penn | Penn Today

David Meaney, PhD, who has served as Senior Associate Dean of Penn Engineering since 2020, has succeeded Dr. Dawn Bonnell as Vice Provost for Research.

Penn Medicine Highlights Public Funding’s Role in Translating Scientific Discoveries into Life-Saving Treatments  

Stephen Bagley, MD, MSCE, Assistant Professor of Hematology-Oncology and Neurosurgery at Penn Medicine, discusses how he used CAR T cell therapy to shrink a patient's tumor.

Nicholas Siciliano, Chief Executive Officer and Co-Founder of Penn Spinout ViTToria Biotherapeutics, Wins the Science Center’s 2025 Commercialization Award  

Siciliano won the Science Center’s 2025 Commercialization Award in recognition of his outstanding contributions to the commercialization of innovative science and technology. 

Avisi Technologies Present Promising Clinical Data at the American Glaucoma Society  

Avisi is based on technology invented by Igor Bargatin, PhD, Associate Professor of Mechanical Engineering and Applied Mechanics at Penn Engineering.

Apellis’ Empaveli® Gains FDA Approval for Broader Rare Kidney Disease Use  

Penn spinout Apellis received FDA approval for an expanded label for Empaveli®.

Filter

Success Stories

Highlights of the PCI news focused on Penn commercialization accomplishments

All Success Stories
Skip to content